Tae-Young Kim

Dr. Tae-Young Kim

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JHJeremy T. Hines
Jeremy T. Hines
WJWoo-Lam Jo
Woo-Lam Jo
QCQuanjun Cui
Quanjun Cui
MMMichael A. Mont
Michael A. Mont
KKKyung-Hoi Koo
Kyung-Hoi Koo
JPJung-Wee Park
Jung-Wee Park
Hines JT, et al. J Korean Med Sci. 2021 May;36(24):e177. https://doi.org/10.3346/jkms.2021.36.e177

30 November 2020 in Journal of Bone Metabolism
Verified
Journal Article
Open access
PDF file
SASeong Hee Ahn
Seong Hee Ahn
Sang-Min ParkSang-Min Park
Sang-Min Park
SPSo Young Park
So Young Park
Jun-Il YooJun-Il Yoo
Jun-Il Yoo
HJHyoung-Seok Jung
Hyoung-Seok Jung
HKHa Young Kim
Ha Young Kim
The socioeconomic burdens of osteoporosis and related fractures have increased in parallel with population aging. The Korea Society of Bone and Mineral Research published fact sheets on these topics in 2017, 2018, and 2019. This study provides complied epidemiological data based on these fact sheets for understanding current status of osteoporosis in Korea. Data from the Korea National Health and Nutrition Examination Survey (2008–2011) performed by the Korea Centers for Disease Control and Prevention and from National Health Information database (2008–2016) by National Health Insurance Service of Korea was used for analyzing the prevalence and incidence of osteoporosis and related fractures, respectively, fatality rates after fractures, and prescription status of anti-osteoporotic medications (AOMs). Among Korean adults aged ≥50 years, 22.4% and 47.9% had osteopenia or osteoporosis, respectively. Incidences of osteoporotic hip, vertebral, humerus, and distal radius fractures plateaued in 2013. The cumulative incidence of subsequent fractures gradually increased over 4 years of follow-up once an osteoporotic fracture occurred. Crude fatality rates in the first 12 months after hip fracture were 14.0% for women and 21.0% for men. Only 33.5% of patients with osteoporosis took AOMs, and even after an osteoporotic fracture, only 41.9% of patients took AOMs within the following 12 months. Despite a steady increase in AOM prescriptions of ~6% per annum, only 33.2% of patients were medication compliant (medication possession ratio ≥80%) at 12 months after treatment initiation. Continuous efforts are required to diagnose patients at high risk of fracture and ensure proper management in Korea.

1 January 2019 in The Journal of Arthroplasty
Verified
Journal Article
Open access
BYByung-Ho Yoon
Byung-Ho Yoon
LJLynne C. Jones
Lynne C. Jones
Chung-Hwan ChenChung-Hwan Chen
Chung-Hwan Chen
ECEdward Y. Cheng
Edward Y. Cheng
QCQuanjun Cui
Quanjun Cui
KKKyung-Hoi Koo
Kyung-Hoi Koo
Glucocorticoid usage, a leading cause of osteonecrosis of the femoral head (ONFH), and its prevalence was reported in 25%-50% of non-traumatic ONFH patients. Nevertheless, there have been no unified criteria to classify glucocorticoid-associated ONFH (GA-ONFH). In 2015, the Association Research Circulation Osseous addressed the issue of developing a classification scheme. In June 2017, a task force was set up to conduct a Delphi survey concerning ONFH. The task force invited 28 experts in osteonecrosis/bone circulation from 8 countries. Each round of the Delphi survey consists of questionnaires, analysis of replies, and feedback reports to the panel. After 3 rounds of the survey, the panel reached a consensus on the classification criteria. The response rates were 100% (Round 1), 96% (Round 2), and 100% (Round 3), respectively. The consensus on the classification criteria of GA-ONFH included the following: (1) patients should have a history of glucocorticoid use >2 g of prednisolone or its equivalent within a 3-month period; (2) osteonecrosis should be diagnosed within 2 years after glucocorticoid usage, and (3) patients should not have other risk factor(s) besides glucocorticoids. Association Research Circulation Osseous established classification criteria to standardize clinical studies concerning GA-ONFH.

1 January 2019 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
BYByung-Ho Yoon
Byung-Ho Yoon
LJLynne C. Jones
Lynne C. Jones
Chung-Hwan ChenChung-Hwan Chen
Chung-Hwan Chen
ECEdward Y. Cheng
Edward Y. Cheng
QCQuanjun Cui
Quanjun Cui
KKKyung-Hoi Koo
Kyung-Hoi Koo

1 January 2016 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
TKTae-Young Kim
Tae-Young Kim
SJSuhyun Jang
Suhyun Jang
Chanmi ParkChanmi Park
Chanmi Park
ALAhreum Lee
Ahreum Lee
YLYoung-kyun Lee
Young-kyun Lee
YHYong-Chan Ha
Yong-Chan Ha
Kim TY, et al. J Korean Med Sci. 2016 May;31(5):801-805. https://doi.org/10.3346/jkms.2016.31.5.801

6 September 2023 in Hip & Pelvis
Verified
Journal Article
Open access
PDF file
YKYoung-Seung Ko
Young-Seung Ko
JHJoo Hyung Ha
Joo Hyung Ha
JPJung-Wee Park
Jung-Wee Park
YLYoung-kyun Lee
Young-kyun Lee
TKTae-Young Kim
Tae-Young Kim
KKKyung-Hoi Koo
Kyung-Hoi Koo
Ko YS, et al. Hip Pelvis. 2023 Sep;35(3):147-156. https://doi.org/10.5371/hp.2023.35.3.147